✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹31 Cr.
P/E
0.00
  • Vineet Laboratories
  • Concord Drugs
  • Unick Fix-A-Form
FAQs on Vineet Laboratories Ltd. Shareprice

Vineet Laboratories has given lower returns compared to its competitors.
Vineet Laboratories has grown at ~-14.85% over the last 2yrs while peers have grown at a median rate of 22.0%

Vineet Laboratories is not expensive.
Latest PE of Vineet Laboratories is 0.0, while 3 year average PE is 47.98.
Also latest EV/EBITDA of Vineet Laboratories is 0.0 while 3yr average is 12.62.

Growth Table
  • Vineet Laboratories Ltd.
  • Concord Drugs
  • Unick Fix-A-Form
Balance Sheet
  • Vineet Laboratories Ltd.
  • Concord Drugs
  • Unick Fix-A-Form
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Vineet Laboratories Ltd.
  • Concord Drugs
  • Unick Fix-A-Form
Cash Flow
  • Vineet Laboratories Ltd.
  • Concord Drugs
  • Unick Fix-A-Form
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Vineet Laboratories Ltd.
  • Concord Drugs
  • Unick Fix-A-Form
Quarterly Results
  • Vineet Laboratories Ltd.
  • Concord Drugs
  • Unick Fix-A-Form
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Vineet Laboratories Ltd. Financials

Balance sheet of Vineet Laboratories is moderately strong, But short term working capital might become an issue for this company.

The debt of Vineet Laboratories is decreasing.
Latest debt of Vineet Laboratories is ₹38.96 Crs as of Dec-24.
This is less than Mar-24 when it was ₹43.52 Crs.

No, profit is decreasing.
The profit of Vineet Laboratories is -₹7.74 Crs for TTM, ₹1.03 Crs for Mar 2024 and ₹1.25 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Vineet Laboratories latest dividend payout ratio is 13.89% and 3yr average dividend payout ratio is 13.89%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech